Target intelligence / Profile preview

Microbial oxidoreductase enzyme

Molecular classification
Enzyme, Oxidoreductase, Oxygenase
01

Overview

Microbial oxidoreductase enzymes are a broad class of proteins produced by microorganisms (bacteria, fungi, and archaea) that catalyze oxidation-reduction reactions, using molecular oxygen or other electron acceptors. Major types include laccases, monooxygenases, dioxygenases, and cytochrome P450s. These enzymes play essential roles in the transformation and degradation of organic molecules, including hydrocarbons, lignin, pollutants, and drugs, thereby impacting the global carbon cycle, environmental health, and microbial metabolism. They are important both as drug targets (in antimicrobial development) and as industrial biocatalysts for processes ranging from bioremediation to biofuel and pharmaceutical synthesis.

Other names
Microbial oxidoreductaseMicrobial oxidative enzymeMicrobial oxygenaseMicrobial monooxygenaseMicrobial dioxygenaseMicrobial laccaseMicrobial P450
02

Mechanism of action

Catalysis of oxidation-reduction (redox) reactions by transferring electrons from substrates to oxygen or other acceptors Biodegradation through bond cleavage and molecular modification

03

Biological functions

Oxidation of organic moleculesEnvironmental pollutant degradation (bioremediation)Metabolism of hydrocarbons and xenobioticsCarbon cycle maintenanceAntibiotic and secondary metabolite biosynthesis
04

Disease associations

Infection (targets for antimicrobial therapies)Pollution and environmental toxin degradationOther (bioprocess/biofuel contexts, not direct human disease)
05

Safety considerations

Non-specific oxidation can generate toxic intermediates/reactive oxygen speciesOff-target effects in therapeutic contexts (e.g., inhibition of host vs. microbial P450)Environmental persistence and incomplete degradation leading to secondary pollutants
06

Interacting drugs

No single set; various antimicrobials and industrial inhibitors/activators may target these enzymes, especially P450 inhibitors in antifungal and antibacterial therapy
07

Biomarkers

Could include measurement of enzyme activity (oxidoreductase assays)detection of specific oxidative metabolitesor abundance of gene/protein markers in microbiome/metagenome studies

Beyond the preview

Go deeper on Microbial oxidoreductase enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial oxidoreductase enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call